LI Yuanhua, SONG Xiuchan, QI Yingjing, ZENG Peiyang, WU Suhua, LAI Zhijun, XIE Shufeng. Value of plasma procalcitonin level detection in treatment of pyemia[J]. Journal of Clinical Medicine in Practice, 2014, (15): 155-157. DOI: 10.7619/jcmp.201415054
Citation: LI Yuanhua, SONG Xiuchan, QI Yingjing, ZENG Peiyang, WU Suhua, LAI Zhijun, XIE Shufeng. Value of plasma procalcitonin level detection in treatment of pyemia[J]. Journal of Clinical Medicine in Practice, 2014, (15): 155-157. DOI: 10.7619/jcmp.201415054

Value of plasma procalcitonin level detection in treatment of pyemia

More Information
  • Published Date: September 10, 2014
  • Objective To explore the value of plasma procalcitonin (PCT)detection in dif-ferentiation and judgment of severe pyemia.Methods 70 patients with pyemia were divided into general pyemia group (n =23),severe pyemia group (n =28)and pyemia shock group (n =19), and plasma PCT,lactic acid,c-reactive protein,the acute physiology and chronic health evaluationⅡ 24 hours (APACHE Ⅱ)and 1,2,3 days in hospital as well as serum PCT,lactic acid,c-reac-tive protein were detected and compared.Results Plasma PCT,lactic acid,CRP and APACHE Ⅱscore of pyemia shock patients were significantly higher than the general pyemia group (P <0.05). Serum PCT,CRP and APACHE Ⅱ score of pyemia shock patients were significantly higher than that of severe pyemia group (P <0.05).15 patients with pyemia died,55 patients survived.72 hours plasma PCT,lactic acid,CRP and APACHE Ⅱ score in death group were significantly higher than the survival group (P < 0.01).When pyemia patients were admitted to hospital,PCT were positively correlated with APACHE Ⅱ scores (r =0.528,P <0.01).Conclusion PCT is superior to the current clinical application of CRP inflammatory response parameters,and it can be used as an early identification of systemic infection,judgment of pyemia severity and prognosis judgment in-dex.
  • Related Articles

    [1]YAO Binbin, SHEN Yan, YANG Hongli, FENG Sujuan, HUANG Huaxing, ZHU Xueling, SHEN Lianglan. Impact of serum cystatin C and hypersensitivity C-reactive protein on the 3-year survival of patients undergoing maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2024, 28(18): 68-75, 80. DOI: 10.7619/jcmp.20240283
    [2]PENG Shunxian, TAO Hua, CHEN Xiaofeng, PENG Jifang, JIANG Shudi. Application value of C-reactive protein to albumin ratio combined with grip strength and serum prealbumin in patients with esophageal cancer[J]. Journal of Clinical Medicine in Practice, 2024, 28(17): 15-19, 26. DOI: 10.7619/jcmp.20242187
    [3]PAN Yan, LI Runpu, XU Yangtao, WANG Yanli, TIAN Zhigang, MA Shenghui. Value of serum carbohydrate antigen 19-9, endothelial cell specific molecule 1 and C-reactive protein to albumin ratio in diagnosis and evaluating prognosis of colorectal cancer[J]. Journal of Clinical Medicine in Practice, 2022, 26(3): 95-100. DOI: 10.7619/jcmp.20213151
    [4]MENG Chao, FAN Zhiqiang, TONG Qing, ZHU Guijun, ZHU Hui. Value of prognostic assessment of soluble triggering receptor expressed on myeloid cell-1, high-sensitivity C-reactive protein combined with the Acute Physiology and Chronic Health Evaluation Ⅱ score in patients with pneumonia complicated with respiratory failure[J]. Journal of Clinical Medicine in Practice, 2021, 25(21): 88-92, 101. DOI: 10.7619/jcmp.20211056
    [5]GONG Xiaoyong, HU Xiaowei, HE Fei, HU Jianping. Correlations between serum levels of brain natriuretic peptide, hypersensitive C-reactive protein as well as creatine kinase isoenzyme and prognosis of patients after percutaneous coronary intervention[J]. Journal of Clinical Medicine in Practice, 2021, 25(11): 72-76. DOI: 10.7619/jcmp.20211053
    [6]LI Jiancheng, XU Gangzheng. Value of hypersensitivity C-reactive protein in predicting the prognosis of coronary heart disease patients with interventional therapy[J]. Journal of Clinical Medicine in Practice, 2020, 24(18): 34-36. DOI: 10.7619/jcmp.202018009
    [7]GAO Zhangdai, WU Bin, QI Lijun, ZHENG Xiyuan. Relationship between serum B-type natriuretic peptide, D-dimer, C reactive protein and short-termprognosis in patients with massive cerebral infarction in subacute phase[J]. Journal of Clinical Medicine in Practice, 2019, 23(14): 32-35. DOI: 10.7619/jcmp.201914008
    [8]LU Yunnan, HUA Ye, FENG Zhiqiang, MA Tao, HE Peicheng, WU Shuangshuang, XU Hong. Effect of edaravone combined with statins on serum homocysteine, C-reactive protein and lipid levels in patients with ischemic stroke[J]. Journal of Clinical Medicine in Practice, 2017, (19): 27-30. DOI: 10.7619/jcmp.201719008
    [9]MENG Meixia, ZHANG Li, WANG Chang, ZHANG Yuan. Study on the correlation between the levels of serum cardiac troponin T, C-reactive protein and the prognosis in patients with maintenance hemodialysis[J]. Journal of Clinical Medicine in Practice, 2017, (1): 45-47,51. DOI: 10.7619/jcmp.201701013
    [10]YE Yonggang, JIANG LI, WANG Yin, XU Yingjie, YUE Jingwen. Correlational study on the effects of C reactive protein and fasting blood glucose to short-term outcomes in patients with acute coronary syndrome[J]. Journal of Clinical Medicine in Practice, 2013, (9): 19-22. DOI: 10.7619/jcmp.201309006
  • Cited by

    Periodical cited type(9)

    1. 马雪萍,王晓丽,阿里木江·司马义,徐桂萍. 腹股沟上髂筋膜阻滞复合全身麻醉对高龄髋关节置换患者术后谵妄发生的影响. 新疆医学. 2022(02): 131-134 .
    2. 张宏,李淑萍. 老年患者髋关节置换术后谵妄的发生现状及其相关影响因素分析. 长春中医药大学学报. 2022(10): 1155-1159 .
    3. 刘贵政,郑婷婷,杜斌. 老年髋部骨折患者术后谵妄发生现况及危险因素研究. 贵州医药. 2022(09): 1405-1406 .
    4. 王秀环,鲍乐乐,马漪洁,陈宁宁. 不同麻醉方法对老年髋关节置换患者术后谵妄发生的影响. 广州医科大学学报. 2021(02): 40-44 .
    5. 刘丹,杨万翔. 人文关怀护理对人工髋关节置换术后谵妄患者临床症状的影响. 中国当代医药. 2021(25): 270-272+276 .
    6. 陈立红,徐芙蓉,叶洁玉,许华亮. 高龄骨科髋关节置换术后患者发生谵妄的危险因素分析. 现代医学与健康研究电子杂志. 2021(23): 115-118 .
    7. 毛俊岚. 高龄患者髋关节置换术后谵妄1例的护理. 基层医学论坛. 2020(03): 420-421 .
    8. 欧玉琼,吴建颖,周嫦娥. 以临床路径为指导的谵妄管理对老年股骨头置换术后患者的影响. 护理实践与研究. 2020(02): 86-88 .
    9. 姜红卫. 骨科老年患者髋关节术后谵妄发生原因及疼痛干预护理进展. 系统医学. 2020(13): 196-198 .

    Other cited types(1)

Catalog

    Article views (216) PDF downloads (0) Cited by(10)

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return